Health
Breast Cancer Drug Trial Fails to Impress
AstraZeneca's breast cancer pill failed in a pivotal trial, failing to improve patient outcomes. This setback could limit the drug’s future use and impact on treatment strategies.
Coverage timeline — 1 article
STAT News
A pill from AstraZeneca failed to improve outcomes in closely watched breast cancer study, a result that could limit the use of the medicine.
2026-09-12 07:09 UTC